Periodontal ligament cells may play an important role in the successful regeneration of the periodontium. We investigated the effects of recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the most potent growth factors that stimulates osteoblast differentiation and bone formation, on cell growth and osteoblastic differentiation in human periodontal ligament cells (HPLC) isolated from four adult patients. rhBMP-2 induced no significant changes in cell growth in any of the HPLCs. rhBMP-2 at concentrations over 50 ng/mL significantly stimulated alkaline phosphatase (ALPase) activity and parathyroid hormone (PTH)-dependent 3', 5'-cyclic adenosine monophosphate accumulation, which are early markers of osteoblast differentiation, in the HPLCs. rhBMP-2 (500 ng/mL) also slightly enhanced the level of PTH/PTH-related peptide receptor mRNA expression in these cells. While interleukin-1β enhanced ALPase activity stimulated with rhBMP-2, tumor necrosis factor-a inhibited the rhBMP-2-stimulated activity. Interleukin-6 induced no significant changes in ALPase activity stimulated with rhBMP-2. Although HPLCs, whether treated with rhBMP-2 or not, could not produce measurable amounts of osteocalcin, which is a marker of more mature osteoblasts, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] induced osteocalcin mRNA expression and protein synthesis in these cells. rhBMP-2 inhibited 1,25(OH)2D3-induced osteocalcin synthesis in HPLCs at both the mRNA and protein levels. These results suggest that rhBMP-2 provides an anabolic effect on periodontal regeneration by stimulation of osteoblastic differentiation in human periodontal ligament cells, and that this stimulatory effect is differentially modulated by inflammatory cytokines during the course of periodontal regeneration.
Ahrens M., Ankenbauer T., Schroder D., Hollnagel A., Mayer H., Gross G. (1993). Expression of human bone morphogenetic protein-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol12:871-880.
2.
Amedee J., Bareille R., Rouais F., Cunningham N., Reddi H., Harmand MF (1994). Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differetiation of osteoprogenitors in human bone marrow. Differentiation58:157-164.
Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem72:248-254.
5.
Celeste AJ, Rosen V., Buecker JL, Kriz R., Wang EA, Wozney JM (1986). Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J5:1885-1890.
6.
Centrella M., McCarthy TL, Canalis E. (1989). Platelet-derived growth factor enhances deoxyribonucleic acid and collagen synthesis in osteoblast-enriched cultures from fetal rat parietal bone. Endocrinology125:13-19.
7.
Chen TL, Bates RL, Dudley A., Hammonds RG, Amento EP (1991). Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: comparison with TGF-β 1. J Bone Miner Res6:1387-1393.
8.
Cho MI, Matsuda N., Lin WL, Moshier A., Ramakrishnan PR (1992). In vitro formation of mineralized nodules by periodontal ligament cells from the rat. Calcif Tissue Int50:459-467.
9.
Cho MI, Matsuda N., Ramakrishnan PR, Lin WL, Genco RJ (1994). Differential regulation of periodontal ligament cell activities by platelet-derived growth factor, insulin-like growth factor I, and epidermal growth factor. In: Molecular pathogenesis of periodontal disease. Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, editors. Washington, DC: ASM Press, pp. 403-414.
10.
Cook SD, Wolfe MW, Salkeld SL, Reuger DC (1995). Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am77:734-750.
11.
Fujimori Y., Nakamura T., Ijiri S., Shimizu K., Yamamuro T. (1992). Heterotrophic bone formation induced by bone morphogenetic protein in mice with collagen-induced arthritis. Biochem Biophys Res Commun186:1362-1367.
12.
Fukumoto S., Suzawa M., Takeuchi Y., Kodama Y., Nakayama K., Ogata E., et al. (1996). Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab81:2554-2558.
13.
Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME, Henning GE, Hipp J., et al. (1993). Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop293:317-326.
14.
Gottlow J. (1994). Principles of regenerative therapy. In: Molecular pathogenesis of periodontal disease. Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, editors. Washington, DC : ASM Press, pp. 393-401.
15.
Hiraki Y., Inoue H., Shigeno C., Sanma Y., Bentz H., Rosen DM, et al. (1991). Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res6:1373-1385.
16.
Hughes FJ, Collyer J., Stanfield M., Goodman SA (1995). The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology136:2671-2677.
17.
Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney JM, Rosen V., et al. (1990). The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun172:295-299.
18.
Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol127:1755-1766.
19.
Kinoshita A., Oda S., Takahashi K., Yokota S., Ishikawa I. (1997). Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in Beagle dogs. J Periodontol68:103-109.
20.
Knutsen R., Wergedal JE, Sampath TK, Baylink DJ, Mohan S. (1993). Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem Biophys Res Commun194:1352-1358.
21.
Labarca C., Paigen K. (1980). Simple, rapid, and sensitive DNA assay procedure . Anal Biochem102:344-352.
22.
Lecanda F., Avioli LV, Cheng SL (1997). Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem67:386-396.
23.
Linkhart S., Mohan S., Linkhart TA, Kumegawa M., Baylink DJ (1986). Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1) . J Cell Physiol128:307-312.
24.
Lynch SE, Williams RC, Polson AM, Howell TH, Reddy MS, Zappa UE, et al. (1989). A combination of platelet-derived growth factor and insulin-like growth factor enhances periodontal regeneration. J Clin Periodontol16:545-547.
25.
Lynch SE, de Castilla GR, Williams RC, Kiristy CP, Howell TH, Reddy MS, et al. (1991). The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol62 :458-468.
26.
Mahy RR, Urist MR (1988). Experimental heterotrophic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B. Clin Orthop237:236-244.
27.
Matsuda N., Lin WL, Kumar NM, Cho MI, Genco RJ (1992). Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol63:515-525.
28.
Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immuno Meth65:55-63.
29.
Nakase T., Takaoka K., Masuhara K., Shimizu K., Yoshikawa H., Ochi T. ( 1997). Interleukin-1β enhances and tumor necrosis factor-a inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone21:17-21.
30.
Noda M., Yoon K., Prince CW, Butler WT, Rodan GA (1988). Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type β transforming growth factor. J Biol Cliem263:13916-13921.
31.
Nojima N., Kobayashi M., Shionome M., Takahashi N., Suda T., Hasegawa K. (1990). Fibroblastic cells derived from bovine periodontal ligaments have the phenotypes of osteoblasts. J Periodont Res25:179-185.
32.
Oates TW, Rouse CA, Cochran DL (1993). Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J Periodontol64:142-148.
33.
Pfeilschifter J., Oechsner M., Naumann A., Gronwald RG, Minne HW, Ziegler R. (1990). Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor β. Endocrinology127:69-75.
34.
Piche JE, Graves DT (1989). Study of the growth factor requirements of human bone-derived cells: a comparison with human fibroblasts. Bone10:131-138.
35.
Piche JE, Carnes DL, Graves DT (1989). Initial characterization of cells derived from human periodontia. J Dent Res68:761-767.
36.
Quintero JC, Piesco NP, Langkamp HH, Bowen L., Agarwal S. (1995). LPS responsiveness in periodontal ligament cells is regulated by tumor necrosis factor-α. J Dent Res74:1802-1811.
37.
Rutherford RB, Niekrash CE, Kennedy JE, Charette MF (1992). Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodont Res27:285-290.
38.
Shibano K., Watanabe J., Iwamoto M., Ogawa R., Kanamura S. (1998). Culture of stromal cells derived from medullary cavity of human long bone in the presence of 1,25-dihydroxyvitamin D3, recombinant human bone morphogenetic protein-2, or ipriflavone. Bone22:251-258.
39.
Sigurdsson TJ, Lee MB, Kubota K., Turek TJ, Wozney JM, Wikesjo UM (1995a). Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration . J Periodontol66:131-138.
40.
Sigurdsson TJ, Tatakis DN, Lee MB, Wikesjo UM (1995b). Periodontal regenerative potential of space-providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J Periodontol66:511-521.
41.
Somerman MJ, Archer SY, Imm GR, Foster RA (1988). A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res67:66-70.
42.
Takeshita A., Niu ZG, Hanazawa S., Takara I., Higuchi H., Katayama I., et al. (1992). Effect of interleukin-1β on gene expressions and functions of fibroblastic cells derived from human periodontal ligament . J Periodont Res27:250-255.
43.
Takiguchi T., Kobayashi M., Suzuki R., Yamaguchi A., Isatsu K., Nishihara T., et al. (1998). Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation and suppresses matrix metalloproteinase-1 production in human bone cells isolated from mandibulae. J Periodont Res33:476-485.
44.
Takuwa Y., Ohse C., Wang EA, Wozney JM, Yamashita K. (1991). Bone morphogenetic protein-2 stimulates alkaline phosphatase activity, and collagen synthesis in cultured osteoblastic cells, MC3T3-El. Biochem Biophys Res Commun174:96-101.
45.
Thies RS, Bauduy M., Ashton BA, Kurtzberg L., Wozney JM, Rosen V. (1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology130:1318-1324.
46.
Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA ( 1991). Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg117 :1101-1112.
Wang EA, Rosen V., D'Alessandro JS, Bauduy M., Cordes P., Harada T., et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA87:2220-2224.
49.
Wang EA, Israel DI, Kelly S., Luxenberg DP (1993). Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors9:57-71.
50.
Wergedal JE, Mohan S., Lundy M., Baylink DJ (1990). Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res5:179-186.
51.
Wozney JM, Rosen V., Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. (1988). Novel regulators of bone formation: molecular clones and activities. Science242:1528-1534.
52.
Yamaguchi A., Katagiri T., Ikeda T., Wozney JM, Rosen V., Wang EA, et al. (1991). Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol113:681-687.
53.
Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney JM, et al. (1996). Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell line, ST2 and MC3T3-G2/PA6 . Biochem Biophys Res Commun220:366-371.
54.
Yasko AW, Lane JM, Fellinger EJ, Rosen V., Wozney JM, Wang EA ( 1992). The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am74:659-670.
55.
Zheng MH, Wood DJ, Papadimitriou JM (1992). What's new in the role of cytokines on osteoblast proliferation and differentiation ? Path Res Pract188:1104-1121.
56.
Zheng MH, Wood DJ, Wysocki S., Papadimitriou JM, Wang EA ( 1994). Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-β1 genes in normal human osteoblast-like cells. J Cell Physiol159:76-82.
